Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cencora Inc (COR)

Cencora Inc (COR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 57,627,448
  • Shares Outstanding, K 193,823
  • Annual Sales, $ 293,959 M
  • Annual Income, $ 1,509 M
  • EBIT $ 4,048 M
  • EBITDA $ 5,166 M
  • 60-Month Beta 0.57
  • Price/Sales 0.20
  • Price/Cash Flow 15.10
  • Price/Book 49.30

Options Overview Details

View History
  • Implied Volatility 29.22% ( +1.78%)
  • Historical Volatility 17.45%
  • IV Percentile 97%
  • IV Rank 64.81%
  • IV High 36.68% on 04/08/25
  • IV Low 15.48% on 11/08/24
  • Put/Call Vol Ratio 2.39
  • Today's Volume 261
  • Volume Avg (30-Day) 817
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 41,731
  • Open Int (30-Day) 41,970

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 3.78
  • Number of Estimates 7
  • High Estimate 3.90
  • Low Estimate 3.65
  • Prior Year 3.34
  • Growth Rate Est. (year over year) +13.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
287.40 +2.72%
on 06/12/25
303.18 -2.63%
on 07/08/25
+8.57 (+2.99%)
since 06/11/25
3-Month
271.00 +8.93%
on 05/12/25
309.35 -4.57%
on 05/07/25
+10.88 (+3.83%)
since 04/11/25
52-Week
218.65 +35.01%
on 10/07/24
309.35 -4.57%
on 05/07/25
+73.21 (+32.98%)
since 07/11/24

Most Recent Stories

More News
ABT's FreeStyle Libre 3 Plus Now Available in Canada: Stock to Rise?

Abbott Laboratories ABT recently made its FreeStyle Libre 3 Plus sensor available to Canadians living with diabetes. This latest generation glucose monitoring device features the world's smallest glucose...

ABT : 132.02 (-1.18%)
BSX : 103.20 (-0.64%)
COR : 295.21 (-0.71%)
ALGN : 202.28 (-1.08%)
Is it Worth Adding Boston Scientific Stock to Your Portfolio Now?

Boston Scientific’s BSX robust MedSurg segment, driven by endoscopy, neuromodulation and urology businesses, is poised for further growth in the upcoming quarters. The long-term prospects of the WATCHMAN...

ABT : 132.02 (-1.18%)
BSX : 103.20 (-0.64%)
COR : 295.21 (-0.71%)
ALGN : 202.28 (-1.08%)
Alcon Stock Gains Following UNITY VCS' Approval in Canada

Alcon Inc.’s ALC UNITY Vitreoretinal Cataract System (“VCS”) has recently received approval from Health Canada. UNITY VCS is the latest innovation from the Alcon Vision Suite — a portfolio of innovative...

ABT : 132.02 (-1.18%)
COR : 295.21 (-0.71%)
ALC : 87.48 (-1.38%)
ALGN : 202.28 (-1.08%)
Here's What to Expect From Cencora's Next Earnings Report

Cencora is scheduled to release its second-quarter results next month, with analysts projecting double-digit earnings growth.

ABT : 132.02 (-1.18%)
XLV : 135.19 (-0.83%)
$SPX : 6,259.75 (-0.33%)
COR : 295.21 (-0.71%)
Is it Apt to Retain Alcon Stock in Your Portfolio for Now?

Alcon’s ALC Vision Care business continues to gain from its diverse portfolio of contact lenses and ocular health products. Additionally, the introduction of new products is poised to help it grow in...

HIMS : 47.89 (-4.73%)
COR : 295.21 (-0.71%)
ALC : 87.48 (-1.38%)
ALGN : 202.28 (-1.08%)
ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?

Abbott Laboratories ABT recently received Health Canada approval for the i-STAT TBI test cartridge for use with whole blood. It is designed to help clinicians assess suspected concussion at the patient's...

ABT : 132.02 (-1.18%)
HIMS : 47.89 (-4.73%)
COR : 295.21 (-0.71%)
ALGN : 202.28 (-1.08%)
How Is Cardinal Health’s Stock Performance Compared to Other Health Care Service Stocks?

Cardinal Health has outperformed its healthcare service peers over the past year, with analysts maintaining a positive outlook on its continued growth trajectory.

XHS : 94.68 (-1.62%)
COR : 295.21 (-0.71%)
CAH : 160.97 (-0.74%)
Is Cencora Stock Outperforming the Dow?

Due to Cencora’s strong performance relative to the broader Dow over the past year, Wall Street analysts remain bullish about the stock’s prospects.

COR : 295.21 (-0.71%)
$DOWI : 44,371.51 (-0.63%)
CAH : 160.97 (-0.74%)
McKesson Stock: Is MCK Outperforming the Healthcare Sector?

McKesson has significantly outpaced the broader healthcare sector over the past year, and analysts remain strongly bullish on the stock’s prospects.

XLV : 135.19 (-0.83%)
MCK : 709.59 (-0.69%)
COR : 295.21 (-0.71%)
MCK Stock Gains More Than 4% Following Strong Q4: Should You Buy Now?

McKesson’s MCK shares have gained 4.4% following its fourth-quarter fiscal 2025 earnings release on May 9. The post-earnings upside reflects growing investor confidence in McKesson’s strategic execution...

MCK : 709.59 (-0.69%)
COR : 295.21 (-0.71%)
CAH : 160.97 (-0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

See More

Key Turning Points

3rd Resistance Point 300.10
2nd Resistance Point 298.46
1st Resistance Point 296.83
Last Price 295.21
1st Support Level 293.57
2nd Support Level 291.93
3rd Support Level 290.30

See More

52-Week High 309.35
Last Price 295.21
Fibonacci 61.8% 274.70
Fibonacci 50% 264.00
Fibonacci 38.2% 253.30
52-Week Low 218.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar